Lisa Beck is the Head of Transactions, Global Business Development at Alexion. In this capacity she is responsible for negotiations and executing transactions for Alexion’s business development deals including in-licenses, out-licenses, research collaborations, co-development and co-commercialization deals, joint ventures and other deals to support Alexion’s corporate strategic goals.  Previously Lisa was at GlaxoSmithKline for over 25 years and has held positions of increasing responsibility in Clinical Development, Project Management, Worldwide Business Development Transactions and R&D Portfolio and Strategy.  Lisa holds Bachelor of Science degree in Biology from Vanderbilt University.